Directorate of Digestive Diseases, University Hospital Aintree, Liverpool, UK.
HPB (Oxford). 2013 May;15(5):372-8. doi: 10.1111/j.1477-2574.2012.00588.x. Epub 2012 Oct 16.
Obstructive jaundice in patients with hilar cholangiocarcinoma is a known risk factor for hepatic failure after liver resection. Plastic stents are most widely used for preoperative drainage. However, plastic stents are known to have limited patency time and therefore, in palliative settings, the self-expanding metal stent (SEMS) is used. This type of stent has been shown to be superior because it allows for rapid biliary decompression and a reduced complication rate after insertion. This study explores the use of the SEMS for biliary decompression in patients with operable hilar cholangiocarcinoma.
A retrospective evaluation of a prospectively maintained database at a tertiary hepatobiliary referral centre was carried out. All patients with resectable cholangiocarcinoma were recorded.
Of 260 patients referred to this unit with cholangiocarcinoma between January 2008 and April 2012, 50 patients presented with operable cholangiocarcinoma and 27 of these had obstructive jaundice requiring stenting. Ten patients were initially treated with SEMSs; no stent failure occurred in these patients. Seventeen patients initially received plastic stents, seven of which failed in the interval between stent placement and laparotomy. These stents were replaced by SEMSs in four patients and by plastic stents in three patients. Median time to laparotomy was 45 days and 68 days in patients with SEMSs and plastic stents, respectively.
Self-expanding metal stents provide adequate and rapid biliary drainage in patients with obstruction caused by hilar cholangiocarcinoma. No re-interventions were required. This probably reflects the relatively short interval between stent placement and laparotomy.
肝门部胆管癌患者的阻塞性黄疸是肝切除术后肝衰竭的已知危险因素。塑料支架是最广泛用于术前引流的。然而,众所周知,塑料支架的通畅时间有限,因此,在姑息治疗中,使用自膨式金属支架(SEMS)。这种类型的支架已被证明是优越的,因为它允许快速胆道减压,并在插入后降低并发症发生率。本研究探讨了 SEMS 在可切除肝门部胆管癌患者中的胆道减压作用。
对一家三级肝胆转诊中心前瞻性维护的数据库进行回顾性评估。所有可切除的胆管癌患者均被记录。
在 2008 年 1 月至 2012 年 4 月期间,有 260 例患者被转诊至该单位患有胆管癌,其中 50 例患者患有可切除的胆管癌,其中 27 例患者因阻塞性黄疸需要支架置入。10 例患者最初接受 SEMS 治疗;这些患者中没有支架失败。17 例患者最初接受塑料支架治疗,其中 7 例在支架放置和剖腹术之间发生支架失败。在 4 例患者中,这些支架被 SEMS 取代,在 3 例患者中被塑料支架取代。SEMS 和塑料支架组患者的中位剖腹术时间分别为 45 天和 68 天。
自膨式金属支架可为肝门部胆管癌引起的梗阻患者提供充足且快速的胆道引流。不需要再次介入。这可能反映了支架放置和剖腹术之间的间隔相对较短。